Celularity Inc
For the period ended Dec 31, 2024. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 8, 2025
CELU$0.71-6.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Revenues | ||
| Product sales, net | $35,336 | $13,149 |
| Services | 5,140 | 5,441 |
| License, royalty and other | 13,744 | 4,181 |
| Total net revenues | 54,220 | 22,771 |
| Operating expenses | ||
| Cost of revenues (excluding amortization of acquired intangible assets) | ||
| Product sales | 4,924 | 8,628 |
| Services | 1,172 | 1,650 |
| License, royalty and other | 8,893 | 5,738 |
| Research and development | 17,386 | 30,465 |
| Selling, general and administrative | 58,643 | 50,576 |
| Change in fair value of contingent consideration liability | (193) | (104,339) |
| Goodwill impairment | — | 112,347 |
| IPR&D impairment | — | 107,800 |
| Amortization of acquired intangible assets | 1,753 | 2,193 |
| Total operating expenses | 92,578 | 215,058 |
| Loss from operations | (38,358) | (192,287) |
| Other income (expense): | ||
| Interest income | 331 | 320 |
| Interest expense | (6,264) | (3,015) |
| Change in fair value of warrant liabilities | 398 | 6,164 |
| Change in fair value of debt | (492) | (1,177) |
| Loss on debt extinguishment | (3,908) | — |
| Other expense, net | (9,599) | (6,290) |
| Total other expense | (19,534) | (3,998) |
| Loss before income taxes | (57,892) | (196,285) |
| Income tax expense | — | 10 |
| Net loss | $(57,892) | $(196,295) |
| Change in fair value of debt due to change in credit risk, net of tax | (5) | 146 |
| Other comprehensive (loss) income | (5) | 146 |
| Comprehensive loss | $(57,897) | $(196,149) |
| Share information: | ||
| Net loss per share – basic and diluted | $(2.64) | $(11.02) |
| Weighted average shares outstanding – basic and diluted | 21,890,518 | 17,813,044 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.